Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol
Introduction Iron deficiency anaemia (IDA) is the most common systemic manifestation of inflammatory bowel disease (IBD) that has detrimental effects on quality of life (QoL) and disease outcomes. Iron deficiency (ID), with or without anaemia, poses a diagnostic and therapeutic challenge in patients...
Main Authors: | Andrea E van der Meulen-de Jong, Gerard Dijkstra, Zlatan Mujagic, Marjolijn Duijvestein, Rogier L Goetgebuer, Roberta Loveikyte |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/1/e077511.full |
Similar Items
-
The effect of iron therapy on oxidative stress and intestinal microbiota in inflammatory bowel diseases: A review on the conundrum
by: R. Loveikyte, et al.
Published: (2023-12-01) -
Investigating Patient Perspectives on Using eHealth Technologies for the Self-Management of Inflammatory Bowel Disease: Mixed Methods Study
by: Sander Hermsen, et al.
Published: (2024-09-01) -
Iron metabolism and diagnostic of iron deficiency in inflammatory bowel diseases
by: Boyko T.I.
Published: (2013-10-01) -
Probiotic vesicles as supplement for inflammatory bowel disease treatment
by: Pun, Song Yi
Published: (2023) -
Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease
by: Bahez Gareb, et al.
Published: (2020-06-01)